Cancer rapid screening test PNACIamp™

celltissuefor RT-PCR

PANAMutyper™ EML4-ALK Screening Kit is the qualitative diagnostic test kit which is able to detect 16 different EML4-ALK fusion genes of tissue from non-small cell lung cancer (NSCLC) patients using peptide nucleic acid (PNA) probes in a real-time PCR system. The PANAMutyper™ EML4-ALK Screening Kit is intended as an aid for screening EML4-ALK fusion-positive NSCLC patients who would be sensitive for receiving ALK inhibitor therapy such as crizotinib. The PANAMutyper™ EML4-ALK Screening Kit is an in vitro diagnostic reagent for detecting 16 different EML4-ALK fusion genes of formalin-fixed paraffin-embedded (FFPE) tissue fresh, tissues and biopsy tissues from non-small cell lung cancer (NSCLC) patients. FEATURES One-step RT-PCR technology Detection of 16 EML4-ALK fusion gene variants in one tube reaction High sensitivity, specificity and reproducibility Short running time Simple workflow Easy result reading by automatic analyzing program